medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2006, Number 3

<< Back Next >>

Cir Plast 2006; 16 (3)

Treatment of facial angiofibromas. A case report

Gutiérrez GC, Barona AD, Pérez DM

Language: Spanish
References: 12
Page: 136-141
PDF size: 805.59 Kb.


ABSTRACT

Tuberous sclerosis is a dominant autosomal inherited disease clinically characterized by mental retardation, seizures and angiofibromas. Facial angiofibromas start with erithematous papules in patients between 4 and 10 years old, and grow progressively. They are present in 70 to 83% of the cases and spread on the nose, nasolabial folds and chin. Facial angiofibromas are anti esthetic, produce bleeding, cutaneous infections because of the difficulty to clean between vegetative lesions, and nostril and vision obstruction. Several treatments have been proposed like shaving excision in the first step and dermabrasion second step; carbon dioxide laser resurfacing with some side effects, cryosurgery and argon laser. A case with resection and coagulation of the lesions in one step with very satisfactory results is reported.


REFERENCES

  1. Von Recklinghausen F. Ein Herz von einem Neugeborenen welches mehrer Theils nach aussen, Theils nach den hohlen prominierende Tumoren (Myomen) trug. Verh Ges Geburtsh Monatsschr Geburtskd 1862; 220: 1.

  2. Bourneville DM. Sclérose tubéreuse des circumvolutions cérébrales: Idiotie et épilepsie hémiplégique. Arch Neurol (Paris) 1880; 1: 81.

  3. Pringle JJ. A case of congenital adenoma sebaceum. Br J Dermatol 1890; 2: 1.

  4. Narayanan V. Tuberous sclerosis complex genetics to pathogenesis. Pediatr Neurol 2003; 29(5): 404-409.

  5. Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ. Molecular genetic advances in tuberous sclerosis. Hum Genet 2000; 107: 97-114.

  6. Van Slegtenhorst M, Nellist M, Nagelkerken B et al. Interaction Between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 1998M; 7: 1053-1057.

  7. Benvenuto G, Li S, Brown SJ et al. The tuberous sclerosis-1(TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 2000; 19: 6306-6316.

  8. Potter CJ , Huang H, Hu T. Drosophila Tsc 1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation and organ size. Cell 2001; 105: 357-368.

  9. Orozco-Covarrubias ML, Ridaura C, Tamayo-Sánchez L. Tuberous sclerosis. early diagnosis with autonomic nervous system responses in hypo pigmented skin. Rev Invest Clin 1994; 46(5): 349-354.

  10. Roach ES. Neurocutaneous syndromes. Pediatr Clin North Am 1992; 39(4): 591-600.

  11. Kandt RS. Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases. Neurol Clin N Am 2003: 983-1004.

  12. Verheyden CN. Treatment of the facial angiofibromas of tuberous sclerosis. Plast Reconstr Surg 1996; 98(5): 777-82.




2020     |     www.medigraphic.com